What Are Nootropic Peptides?
An introduction to peptides marketed for cognitive enhancement, including Semax, Selank, and Dihexa. Learn what the evidence actually shows versus marketing claims.
What Are Nootropic Peptides?
Nootropic peptides are peptides marketed to enhance cognitive function, including memory, focus, learning, and mental clarity. The term “nootropic” comes from Greek words meaning “mind-turning.”
Common Nootropic Peptides
| Peptide | Origin | Claimed Effects |
|---|---|---|
| Semax | Synthetic ACTH fragment | Memory, focus, neuroprotection |
| Selank | Synthetic tuftsin analog | Anxiety, cognition, mood |
| Dihexa | Synthetic small peptide | Memory, neuroplasticity |
| P21 | CNTF-derived peptide | Neurogenesis, memory |
| Cerebrolysin | Porcine brain extract | Stroke recovery, dementia |
How Are They Claimed to Work?
Semax
- Modulates BDNF (brain-derived neurotrophic factor)
- May affect dopamine and serotonin systems
- Proposed neuroprotective effects
Selank
- Affects GABA system (calming)
- May modulate immune function
- Claimed anxiolytic (anti-anxiety) effects
Dihexa
- Proposed to enhance hepatocyte growth factor (HGF) signaling
- May promote synapse formation
- Claimed to be extremely potent (animal data only)
What Does the Evidence Show?
Evidence by Peptide
| Peptide | Human Studies | FDA Status |
|---|---|---|
| Semax | Some (mostly Russian) | Not FDA approved |
| Selank | Some (mostly Russian) | Not FDA approved |
| Dihexa | None published | Not approved |
| P21 | None published | Not approved |
| Cerebrolysin | Yes (limited) | Not FDA approved |
Important Context
- Semax and Selank are approved in Russia for specific medical conditions but not in the US or EU
- Most human studies come from Russian researchers and may not meet Western clinical trial standards
- Dihexa and P21 have only animal data despite marketing claims
- Cerebrolysin has some clinical trials but remains unapproved in most Western countries
Regulatory Considerations
In the United States:
- None of these peptides are FDA-approved
- They cannot legally be sold for human consumption
- Products are typically labeled “for research use only”
- Quality and purity are not guaranteed
Why the Uncertainty?
Several factors make nootropic peptide evidence difficult to evaluate:
- Publication bias — Positive results more likely to be published
- Small sample sizes — Most studies have few participants
- Lack of replication — Few independent confirmations
- Measuring cognition is hard — Subjective outcomes are unreliable
- Placebo effects — Expectations strongly affect perceived cognition
Important Warnings
- Not approved for any use in the US
- Unregulated products may be contaminated or mislabeled
- Long-term effects are completely unknown
- Drug interactions have not been studied
- Brain effects could be unpredictable
The Bottom Line
While nootropic peptides are popular in biohacking communities, the evidence base is limited. Most claims rely on animal studies or small, poorly-controlled human trials. Anyone considering these compounds should understand they are experimental with unknown long-term risks.
This guide is for educational purposes only. Nootropic peptides are not approved for medical use in the United States.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. The information presented is based on current research but should not be used for diagnosis, treatment, or prevention of any disease. Always consult a qualified healthcare provider before making health decisions.